ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 420

Machine Learning in Rheumatology: Development and Validation of a Predictive Model for Rheumatoid Arthritis Mortality Using Random Survival Forests

Luis Rodriguez-Rodriguez1, José M Lezcano-Valverde2, Fernando Salazar3, Leticia León2, Esther Toledano4, Juan A Jover Jover5, Eduardo Soudah3, Benjamín Fernández-Gutiérrez5, Isidoro Gonzalez-Alvaro6 and Lydia A Alcazar1, 1Rheumatology Department and Heath Research Institute (IdISSC), Hospital Clinico San Carlos, Madrid, Spain, 2Rheumatology Department, Hospital Clínical San Carlos, and IdISSC, Madrid, Spain, 3International Centre for Numerical Methods in Engineering (CIMNE), Madrid, Spain, 4Rheumatology, Hospital Clínical San Carlos, Madrid, Spain, 5Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, 6Rheumatology Department, Hospital Universitario la Princesa, IIS-Princesa, Madrid, Spain

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: morbidity and mortality and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster I: Treatment Patterns and Response

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is associated with increased mortality. Traditional survival techniques used to identify mortality risk factors, such as the Cox proportional hazards model (CPH), have several limitations, such as reliance on restrictive assumptions. To overcome these limitations, machine learning methods have been developed. Random survival forest (RSF), a non-parametric ensemble tree method, was proposed as an alternative approach to CPH. Our aim is to develop and validate (internally and externally) a predictive model for RA mortality using RSF.

Methods: Retrospective longitudinal study involving 2 independent RA cohorts from Madrid (Spain): the Hospital Clínico San Carlos RA Cohort (HCSC-RAC: 1,461 patients diagnosed between 2001 and 2011, followed-up until death or September 2013; used for model development), and the Hospital Universitario de La Princesa Early Arthritis Register Longitudinal study (PEARL: 280 patients diagnosed between 2001 and 2014, followed-up until death or January 2017; used for external validation). Demographic and clinical-related variables collected during the first two years after disease diagnosis were used. RSF models were developed with the randomForestSRC R package, based on 1,000 trees. 100 iterations of each model were performed to measure the mean and standard deviation of the prediction error. Based on the predicted mortality estimated by the RSF model, mortality risk groups were established through a survival tree created with the R package rpart.

Results: 148 and 21 patients from the HCSC-RAC and the PEARL died during a median follow-up time of 4.3 and 5.0 years, respectively. Age at diagnosis, median erythrocyte sedimentation rate, and number of hospital admissions in the first 2 years after RA diagnosis showed the higher predictive capacity. The prediction errors of our model in the training and in the validation cohorts were 0.187, and 0.233, respectively. The survival tree analysis identified 5 risk groups. After combining those three with intermediate risk, we observed that the intermediate and the high risk groups were significantly associated with higher mortality risk compared with the low risk, both in the HCSC-RAC and PEARL cohorts (Figures 1 and 2).

Conclusion: We developed and externally validated a clinical prediction model for RA mortality using RSF.

 

 

Figure 1: Kaplan Meier curves for the observed mortality of patients from the HCSC-RAC, grouped in mortality risk categories

 

 

Figure 2: Kaplan Meier curves for the observed mortality of patients from the PEARL, grouped in mortality risk categories


Disclosure: L. Rodriguez-Rodriguez, None; J. M. Lezcano-Valverde, None; F. Salazar, None; L. León, None; E. Toledano, None; J. A. Jover Jover, None; E. Soudah, None; B. Fernández-Gutiérrez, None; I. Gonzalez-Alvaro, None; L. A. Alcazar, None.

To cite this abstract in AMA style:

Rodriguez-Rodriguez L, Lezcano-Valverde JM, Salazar F, León L, Toledano E, Jover Jover JA, Soudah E, Fernández-Gutiérrez B, Gonzalez-Alvaro I, Alcazar LA. Machine Learning in Rheumatology: Development and Validation of a Predictive Model for Rheumatoid Arthritis Mortality Using Random Survival Forests [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/machine-learning-in-rheumatology-development-and-validation-of-a-predictive-model-for-rheumatoid-arthritis-mortality-using-random-survival-forests/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/machine-learning-in-rheumatology-development-and-validation-of-a-predictive-model-for-rheumatoid-arthritis-mortality-using-random-survival-forests/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology